CustomersYachts (@Michaelrose102) header
CustomersYachts (@Michaelrose102) profile picture

Everything comes and goes, may as well trade some paper while we’re at it… Anything about stocks is not advice

New York, NY
Joined September 2019
Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)Photo by CustomersYachts (@Michaelrose102)
$goog making 52 week lows while gemini renters the frontier race and nvidia falters ~ TPU’s positioning improves…. Interesting set-up. Thoughts here? @WaterworldCapi1 @akramsrazor
1
2
218
Anthropic next gen cyber product release in 3,2,1….. $ANT
5 MAJOR DISRUPTIONS IN JUST 6 DAYS 🇺🇸 Nov 17: NSA classified network DOWN 🏦 Nov 16: JPMorgan banking failure ✈️ Nov 16: United Airlines outage 🛑 Nov 13: FAA nationwide ground stop 🌐 Nov 12–13: Microsoft 365 outage No coordinated cyberattack confirmed.
2
182
Oh my lord…
I want to give every American family a $1700 check to make them whole for the war in Iran. Democrats have a chance to deliver. The first week in January, the House and Senate must pass a refund check to Americans. Let’s put it on Trump’s desk.
3
396
Anyone have an opinion on $shaz here? Perhaps not as shitty as it used to be and at $20 underwriting very little execution @ACapitalLP @YellowCatCap @kevin__mak
2
1
2,329
FYI this was inevitable once the labs began going public…multi trillion dollar valuations needs more markets = they’re coming after SaaS. (The biotech stuff is mostly pipe dreams for now). $Ant $igv
Starting to roll out today: Claude Whiteboards, Claude Sheets and Claude Data. Think a plan through on a board, build a tracker in a sheet, and tell a story with your data.
2
2
1,004
$MGM Real world scarcity asset…
Bought $mgm today. Probably should have bought more but also don’t really like the buisness.
225
bear celebrating too fast IMO. This will be a different kind of decel… Also solar interesting here as pretty cheap and your probably looking at 6 years of incredible runway from a regulatory perspective…
1
1
298
Bought $mgm today. Probably should have bought more but also don’t really like the buisness.
1
485
And…we have arrived.. This will probably be my last time commenting on this for a while. Market has provided an opportunity for people with 12-18 month horizon imo. I’ve taken it and am now sized the way i’d like. On to the next one..;) @Biohazard3737
Replying to @Michaelrose102
Looks we’ll be getting to $MDT entry price of $5.75 shortly. @Biohazard3737 @tradingbios $avr
2
7
587
And now kind of asking the same question about $zura… Not crazy about it and specialists + the market are staying away but the r/r has certainly changed (gotten better) …@Biohazard3737
Not necessarily a big fan of $iva but price action of late has certainly changed the r/r…. Anybody negative here with conviction?
1
1,018
Went to $14-15 premarket - now back to $10. Back in the good days they would’ve squeezed this to $40…watching this one in case we get some inter day action @SPACLiquidity
$ATII There were 23,000,000 shares subject to possible redemption. Shareholders elected to redeem 22,219,068 shares of Class A common stock in connection with the meeting. 780,982 shares remain in the public float
1
264
I have resigned myself to waiting to double my position when it gets into the 7’s….probably means it never gets there… @EricTheUmpire
$ccxi I’m not a LT bull. But the r/r here is wild. Only U.SA. humanoid pure play - every private name is ridiculously valued - $amzn owns 7% - $nvda keeps talking them up - and you have NAV protection. Risk a dollar to make $6-7 on a run up into a vote?
226
$AVR. I’ve been adding. •Enrollment has been going well (should finish on time Q1 ‘27). •Ex-pivotal data 1 year 130 patients in November will help de-risk PARADIGM (CEO has seen data - said “consistent with public data”) •Recent deals show how cheap it’s here @Biohazard3737
$AVR Not the kind of name you traditionally look to buy in current market dynamic… But time arbitrage if I’ve ever seen one - and it’s not a bad thing to buy things when no one else wants to because “it’s not the time” @Biohazard3737 @avidresearch @Sanctuary_Bio
1
1
7
1,364
R/R here is egregious IMO. From this levels Pre pivotal data prob downside of $1.25 - upside of $7-8 (IMO fair range pre readout is $12-16) Post data - downside 50% - upside 4x. And that’s for something with consensus high POS
1
1
397
Looks we’ll be getting to $MDT entry price of $5.75 shortly. @Biohazard3737 @tradingbios $avr
1
1
6
947
Just saying an AI slowdown and restrictive posture / rate hikes would be a disaster - and are also probably mutually exclusive…
1
332
Not necessarily a big fan of $iva but price action of late has certainly changed the r/r…. Anybody negative here with conviction?
1
1
1
2,103
$ccxi I’m not a LT bull. But the r/r here is wild. Only U.SA. humanoid pure play - every private name is ridiculously valued - $amzn owns 7% - $nvda keeps talking them up - and you have NAV protection. Risk a dollar to make $6-7 on a run up into a vote?
The one consolation if you missed $CCXI is: There will most likely be a short report at some point pointing at the lack of revenue + how the pilots are meh because customers just taking multiple pilots at a time and then drop. And the Market will care for 1-2 hours. You BTD 🚀
1
7
895
And there you go… $pcvx “$500 million of its common stock and pre-funded warrants and $500 million aggregate principal amount of convertible senior notes due 2032..” teapawt.net/monaco_biotech/status/…
I guess a raise coming AH today for $pcvx? 500m?
1
2
535
$pcvx Wow. Anyone hear pricing here? Surprised to see this back in low 60’s so quickly… @tradingbios @plainyogurt21 @BlaseBio @Sanctuary_Bio
76